Skip to content

US · ICCM · MEDICAL - DEVICES

IceCure Medical Ltd (ICCM) intrinsic value and stock valuation

$0.80as of 2026-11-21 · Mkt cap 6.94M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

IceCure Medical Ltd DCF and intrinsic value

InvestorsCraft values ICCM with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from ICCM’s statements →

IceCure Medical Ltd Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Devices Caesarea, HA 3079504 icecure-medical.com

How the business is doing

Fiscal 2013–2025, USD

Revenue
$3.38M-3.7% 5y CAGRd
20132025
Net income
-$-15.06M
20132025
Free cash flow
-$-14.61M
20132025
Total equity
$9.05M+14.6% 5y CAGRd
20142025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2013–2025, USD
20252024202320222021
Revenue$3.38M$3.29M$3.23M$3.08M$4.14M
Operating income-$-15.09M-$-15.7M-$-15.58M-$-16.74M-$-9.72M
Net income-$-15.06M-$-15.32M-$-14.65M-$-17.22M-$-10.07M
EPSd-$-7.1M-$-9.01M-$-9.64M-$-14M-$-10.6M
Operating cash flow-$-14.57M-$-12.56M-$-12.52M-$-14.29M-$-12.61M
Capital expenditure-$-40K-$-70K-$-480K-$-890K-$-530K
Free cash flow-$-14.61M-$-12.63M-$-13M-$-15.18M-$-13.14M
Total assets$13.9M$12.6M$16.4M$30.2M$32.3M
Total debt$220K$460K$600K$600K$910K
Net debt-$-8.68M-$-7.11M-$-9.93M-$-23.06M-$-24.71M
Total equity$9.05M$6.9M$12.2M$25.4M$27M
Cash and short-term investments$8.9M$7.56M$11.1M$23.7M$25.6M
Income statement
20252024202320222021
Revenue$3.38M$3.29M$3.23M$3.08M$4.14M
Cost of revenue$2.15M$1.84M$1.93M$1.64M$1.94M
Gross profit$1.23M$1.45M$1.3M$1.45M$2.19M
Research and development expenses$7.43M$7.1M$8.27M$9.12M$5.88M
Selling, general and administrative expenses$8.89M$10.1M$8.6M$9.06M$6.04M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$16.3M$17.2M$16.9M$18.2M$11.9M
Cost and expenses$18.5M$19M$18.8M$19.8M$13.9M
Interest income$40K$380K$920K$0.00$0.00
Interest expense$0.00$0.00$0.00$240K$170K
Depreciation and amortization$290K$330K$320K$250K$130K
Ebitda-$-14.8M-$-15.36M-$-15.25M-$-16.49M-$-9.6M
Operating income-$-15.09M-$-15.7M-$-15.58M-$-16.74M-$-9.72M
Total other income/expenses, net$40K$380K$920K-$-240K-$-170K
Income before tax-$-15.06M-$-15.32M-$-14.65M-$-16.98M-$-9.89M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-15.06M-$-15.32M-$-14.65M-$-17.22M-$-10.07M
Weighted average shares outstanding$2.12M$1.7M$1.52M$1.23M$950K
Weighted average diluted shares outstanding$2.12M$1.7M$1.52M$1.23M$950K
Balance sheet
20252024202320222021
Cash and short-term investments$8.9M$7.56M$11.1M$23.7M$25.6M
Net receivables$330K$220K$100K$370K$770K
Inventory$2.62M$1.99M$2.27M$2.86M$1.96M
Total current assets$12.6M$10.8M$14.2M$28.1M$30.3M
Property, plant and equipment, net$1.23M$1.78M$2.19M$2.02M$1.63M
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$50K$0.00$0.00$0.00$0.00
Total non-current assets$1.28M$1.82M$2.23M$2.06M$1.96M
Total assets$13.9M$12.6M$16.4M$30.2M$32.3M
Accounts payable$860K$1.23M$500K$710K$880K
Short-term debt$200K$600K$220K$170K$220K
Deferred revenue$260K$330K$190K$650K$880K
Total current liabilities$4.82M$5.51M$3.87M$4.34M$4.02M
Long-term debt$10K$160K$380K$430K$690K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$10K$160K$380K$430K$1.3M
Capital lease obligations$220K$460K$600K$600K$910K
Total liabilities$4.84M$5.67M$4.25M$4.77M$5.32M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-120.44M-$-105.38M-$-90.06M-$-75.41M-$-58.43M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$9.05M$6.9M$12.2M$25.4M$27M
Total investments$50K$0.00$530K$0.00$0.00
Total debt$220K$460K$600K$600K$910K
Net debt-$-8.68M-$-7.11M-$-9.93M-$-23.06M-$-24.71M
Cash flow statement
20252024202320222021
Net income-$-15.06M-$-15.32M-$-14.65M-$-16.98M-$-9.89M
Depreciation and amortization$290K$330K$320K$250K$130K
Stock-based compensation$1.37M$870K$1.31M$1.86M$320K
Change in working capital-$-1.07M$1.51M$520K$210K-$-3.16M
Accounts receivable-$-110K-$-120K$470K$380K-$-360K
Inventory-$-640K$290K$580K-$-900K-$-890K
Accounts payable-$-370K$730K-$-210K-$-170K$240K
Net cash provided by operating activities-$-14.57M-$-12.56M-$-12.52M-$-14.29M-$-12.61M
Investments in property, plant and equipment-$-40K-$-70K-$-480K-$-890K-$-530K
Acquisitions, net$0.00$0.00$0.00$0.00-$-4.5M
Net cash used for investing activities-$-40K$450K-$-710K-$-890K$3.79M
Common stock issued$15.8M$9.19M$80K$13.6M$30.6M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$15.8M$9.19M$80K$13.6M$30.9M
Net change in cash$1.33M-$-2.97M-$-13.13M-$-1.96M$22.1M
Cash at end of period$8.9M$7.56M$10.5M$23.7M$25.6M
Operating cash flow-$-14.57M-$-12.56M-$-12.52M-$-14.29M-$-12.61M
Capital expenditure-$-40K-$-70K-$-480K-$-890K-$-530K
Free cash flow-$-14.61M-$-12.63M-$-13M-$-15.18M-$-13.14M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About IceCure Medical Ltd

        Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.

        CEO
        Eyal Shamir
        Employees
        68
        Beta
        0.47

        Explore

        Frequently asked questions

        What is the intrinsic value of IceCure Medical Ltd (ICCM)?

        InvestorsCraft does not currently publish an intrinsic value for ICCM. How the IC value is calculated.

        Is ICCM undervalued?

        InvestorsCraft does not publish an undervaluation signal for ICCM at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.